What is Novartis AG’s price-to-earnings ratio (P/E)?

Novartis AG’s P/E ratio is 18.3, indicating how much investors are paying for each unit of net income.

What is Novartis AG’s price-to-sales ratio (P/S)?

Novartis AG’s P/S ratio is 4.69, measuring how the market values the company relative to its revenue.

What is Novartis AG’s price-to-book ratio (P/B)?

Novartis AG’s P/B ratio is 5.81, comparing the market value of the company to its book value.

Novartis AG (NOVN.SW) Valuation Metrics

Price to Earnings

CAGRVariation 10 years

PER

-2.16%

-19.62%

Price to Sales

CAGRVariation 10 years

Price to Sales

+4.26%

+51.81%

Price to Book

CAGRVariation 10 years

Price to Book

+11.03%

+184.77%

Price to Earnings Growth

CAGRVariation 10 years

PEG

+6.03%

+279.58%

Price to Free Cash Flow

CAGRVariation 10 years

Price to Free Cash Flow

-1.99%

-18.19%

Enterprise Value

CAGRVariation 10 years

EV / Revenue

+4.13%

+49.94%

EV / EBITDA

+0.52%

+5.35%

EV / Free Cash Flow

-2.11%

-19.2%

Novartis AG

Novartis AG

Invvest valuation chart ™

Unlock this feature

Customization

Price to Earnings

Price to Sales

Price to Book

Price to Earnings Growth

Price to Free Cash Flow

Enterprise Value

Image Modal

Novartis AG

Image Modal

Novartis AG

Invvest valuation chart ™

Unlock this feature

Customization

Price to Earnings

Price to Sales

Price to Book

Price to Earnings Growth

Price to Free Cash Flow

Enterprise Value

What is Novartis AG’s price-to-earnings ratio (P/E)?

What is Novartis AG’s price-to-sales ratio (P/S)?

What is Novartis AG’s price-to-book ratio (P/B)?